杭州 - WORK Medical Technology Group LTD (NASDAQ:WOK)周一宣布，其子公司湖南赛图莫飞有限公司已获得湖南省医疗产品管理局颁发的II类医疗器械生产许可，用于生产AI自动化人类血细胞形态分析仪。据InvestingPro数据显示，该公司股价目前接近其52周低点2.66美元，过去一年内下跌了近100%。 该设备集成了光学成像系统、样本处理模块和自动化组件，可 ...

In 2026, Medtronic plans to launch a new robot to compete with a legacy market leader. This new robot is reportedly cheaper ...

Investing.com -- WORK Medical Technology Group Ltd (NASDAQ:WOK) 周一股价飙升50.2%，此前这家中国医疗设备供应商宣布其子公司获得了一款AI驱动的血细胞分析仪的生产批准。 这款二类医疗器械——AI自动化人类血细胞形态分析仪获得了湖南省医疗产品管理局的批准。该分析仪结合了高速数字成像和深度学习算法，可以识别和分类外周血涂片中的血细胞。

WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical” or the 'Company”), a supplier of medical devices in China, ...

WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical” or the 'Company”), a supplier of medical devices in China, ...

The use of 3D printing to fabricate patient-specific implants has made great strides over the years, but surgical guides and pre-operative models continue to be the most widespread application of 3D ...

Initiating coverage on Creative Medical Technology Holdings with a Sell rating due to early-stage pipeline and significant downside risks outweighing potential upside. The company’s pipeline includes ...

A first-of-its-kind university that offers specialized, practice oriented, academic programmes in the field of medical ...

Work Medical Technology is effectuating a reverse stock split on a 1-for-100 basis. The Chinese medical-device supplier said Wednesday the decision was made primarily to remain in compliance with ...

WORK Medical Technology Group LTD ( ($WOK) ) just unveiled an announcement. On October 21, 2025, WORK Medical Technology Group LTD shareholders ...

Shanghai Xianxiang Medical Technology Co. Ltd. has synthesized CDK2/cyclin E1 inhibitors reported to be useful for the treatment of cancer.

In the dynamically changing healthcare landscape, innovation alone is not enough. Companies and scientists must form strategic alliances, especially in regions with complex regulatory environments.